Depression Clinical Trial
Official title:
A Randomized Double-blind Placebo-controlled Trial to Working Memory Training in Substance Abusers
Background: Substance abusers show impaired working memory (WM) functioning. Promising
findings show training WM results in an improved working memory capacity (WMC) and a
decrease of clinical symptoms in a range of disorders, including alcohol addiction.
Aim: To test the effect of a WM training in addition to treatment as usual (TAU) on
substance use, craving, WMC, impulsivity, attention bias and psychopathology.
Design: A randomized double-blind placebo-controlled trial with a parallel group design. The
WM training adapted to participants' WMC whereas the placebo training consisted of
non-adaptive easy versions of these tasks.
Setting: Two departments of an addiction treatment clinic in Rotterdam, the Netherlands.
Participants: 120 inpatients diagnosed with an alcohol, cannabis or cocaine dependency who
were in treatment as usual .
Measurements: Primary outcome measures: Substance use and craving. Secondary outcome
measures: WMC, impulsivity, attention bias and psychopathology. Participants were assessed
before and after 24 sessions of WM training as well as two months after the training.
Status | Completed |
Enrollment | 180 |
Est. completion date | June 2014 |
Est. primary completion date | June 2014 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 16 Years to 67 Years |
Eligibility |
Inclusion Criteria: - Substance dependency: cocaine, cannabis or alcohol Exclusion Criteria: - Age below 16 or above 67 - Current psychosis - Neurological complaints |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Netherlands | Bouman Clinic | Rotterdam | Zuid Holland |
Lead Sponsor | Collaborator |
---|---|
Erasmus Medical Center |
Netherlands,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Change in Barratt Impulsivity Scale-11 score on pre and post training and follow up after two months | The 30-item Barratt Impulsivity Scale-11 (BIS-11) measures impulsivity. | Pre (baseline), post (after 4 weeks of training-starting 1 day after pre-test) and follow-up (2 months after post-test) | No |
Other | Change in Stroop score on pre and post training and follow up after two months | The Stroop measures participants' attention bias for addiction related stimuli. | Pre (baseline), post (after 4 weeks of training-starting 1 day after pre-test) and follow-up (2 months after post-test) | No |
Other | Change in Beck Depression Inventory - Second Edition (BDI-II) score on pre and post training and follow up after two months | The Beck Depression Inventory - Second Edition (BDI-II) measures the severity of depression in 21 statements, with four levels of increasing severity each. | Pre (baseline), post (after 4 weeks of training-starting 1 day after pre-test) and follow-up (2 months after post-test) | No |
Other | Change in State-Trait Anxiety Inventory (STAI) score on pre and post training and follow up after two months | The State-Trait Anxiety Inventory (STAI) measures self-reported anxiety in 40 questions on a 4-point scale. The questionnaire consists of two parts; state and trait anxiety, respectively transient and dispositional anxiety. | Pre (baseline), post (after 4 weeks of training-starting 1 day after pre-test) and follow-up (2 months after post-test) | No |
Other | Change in substance use, measured with the Addiction Severity Index over pre-, post (1 day after training) and follow-up (2 months after post-test) measurements. | The Addiction Severity Index (ASI) is a semi-structured interview that measures the severity of addiction in 25 questions concerning seven problem areas: medical problems, employment problems, drug use, alcohol use, family and social problems, criminality, and psychiatric problems. We used three of these questions to assess the severity of participants' abuse problems. | Pre (baseline), post (after 4 weeks of training-starting 1 day after pre-test) and follow-up (2 months after post-test) | No |
Primary | Craving: Desires for Alcohol Questionnaire and Desires for Drug Questionnaire score change and Obsessive Compulsive Drug Use Scale and Obsessive Compulsive Drinking Scale score change between pre and post training and follow up (two months after post) | The 14-item Desires for Drug Questionnaire (DDQ) and the 13-item Desires for Alcohol Questionnaire (DAQ) measure instant craving to respectively drug and alcohol. The DDQ is based on the DAQ. The Obsessive Compulsive Drug Use Scale (OCDUS) and Obsessive Compulsive Drinking Scale (OCDS) measure the subjective interference and distress caused by respectively drug and alcohol related thoughts and compulsive-behavior patterns. |
Pre (baseline), post (after 4 weeks of training-starting 1 day after pre-test) and follow-up (2 months after post-test) | No |
Secondary | Change in Digit Span score on pre and post training and follow up after two months | The Digit Span task consists of two parts: the forward Digit Span is a frequently used measure for short term memory, an important subcomponent of the memory system (Shipstead, Redick, & Engle, 2012) and the backward version measures WM. | Pre (baseline), post (after 4 weeks of training-starting 1 day after pre-test) and follow-up (2 months after post-test) | No |
Secondary | Change in Reading Span partial-scredit uni score on pre and post training and follow up after two months | The Reading Span measures the processing and storage functions of WM (Shipstead et al., 2012), specifically participants' ability to shift between two tasks and to cope with proactive interference. | Pre (baseline), post (after 4 weeks of training-starting 1 day after pre-test) and follow-up (2 months after post-test) | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05777044 -
The Effect of Hatha Yoga on Mental Health
|
N/A | |
Recruiting |
NCT04977232 -
Adjunctive Game Intervention for Anhedonia in MDD Patients
|
N/A | |
Recruiting |
NCT04680611 -
Severe Asthma, MepolizumaB and Affect: SAMBA Study
|
||
Recruiting |
NCT04043052 -
Mobile Technologies and Post-stroke Depression
|
N/A | |
Completed |
NCT04512768 -
Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy
|
N/A | |
Recruiting |
NCT03207828 -
Testing Interventions for Patients With Fibromyalgia and Depression
|
N/A | |
Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
Recruiting |
NCT06011681 -
The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
|
||
Completed |
NCT04476446 -
An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives
|
Phase 3 | |
Recruiting |
NCT02783430 -
Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease
|
Phase 2/Phase 3 | |
Recruiting |
NCT05563805 -
Exploring Virtual Reality Adventure Training Exergaming
|
N/A | |
Completed |
NCT04598165 -
Mobile WACh NEO: Mobile Solutions for Neonatal Health and Maternal Support
|
N/A | |
Completed |
NCT03457714 -
Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
|
||
Recruiting |
NCT05956912 -
Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
|
||
Completed |
NCT05588622 -
Meru Health Program for Cancer Patients With Depression and Anxiety
|
N/A | |
Recruiting |
NCT05234476 -
Behavioral Activation Plus Savoring for University Students
|
N/A | |
Active, not recruiting |
NCT05006976 -
A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study
|
N/A | |
Enrolling by invitation |
NCT03276585 -
Night in Japan Home Sleep Monitoring Study
|
||
Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
Terminated |
NCT03275571 -
HIV, Computerized Depression Therapy & Cognition
|
N/A |